| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Mizuho analyst Anthony Petrone downgrades Hologic (NASDAQ:HOLX) from Outperform to Neutral and raises the price target from ...
Raymond James analyst Andrew Cooper downgrades Hologic (NASDAQ:HOLX) from Outperform to Market Perform.
Stephens & Co. analyst Mason Carrico downgrades Hologic (NASDAQ:HOLX) from Overweight to Equal-Weight and lowers the pri...
JP Morgan analyst Casey Woodring downgrades Hologic (NASDAQ:HOLX) from Overweight to Neutral and announces $78 price target.